Maica Galán

Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer

Ángel Díaz‐Lagares, Ana B. Crujeiras, Paula López-Serra et al. · Proceedings of the National Academy of Sciences · 2016 · 193 citations · Full text

Medicine, Molecular Biology, Oncology +17

Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model

Berta Laquente, Cristina Lacasa, Oriol Casanovas et al. · Molecular Cancer Therapeutics · 2008 · 65 citations · Full text

Medicine, Oncology, Pharmacology +12

Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

Fernando Rivera, Marta Izquierdo-Manuel, Pilar García‐Alfonso et al. · European Journal of Cancer · 2021 · 65 citations

Medicine, Oncology, Surgery +17

Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)

Enrique Aranda, J.L. Manzano, Fernando Rivera et al. · Annals of Oncology · 2011 · 49 citations · Full text

Medicine, Oncology, Pharmacology +12

Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery

Leandre Farràn, M. Sans, Esther Kreisler et al. · Diseases of the Esophagus · 2007 · 39 citations · Full text

Medicine, Oncology, Surgery +16